Bausch Health
BHC
#3706
Rank
ยฃ2.18 B
Marketcap
ยฃ5.94
Share price
1.08%
Change (1 day)
1.06%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ17.11 Billion

According to Bausch Health 's latest financial reports the company's total debt is ยฃ17.11 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31ยฃ17.57 B2.38%
2022-12-31ยฃ17.16 B2.28%
2021-12-31ยฃ16.78 B-4.38%
2020-12-31ยฃ17.55 B-11.12%
2019-12-31ยฃ19.74 B3.13%
2018-12-31ยฃ19.14 B1.71%
2017-12-31ยฃ18.82 B-22.17%
2016-12-31ยฃ24.18 B15.24%
2015-12-31ยฃ20.98 B114.49%
2014-12-31ยฃ9.78 B-7.13%
2013-12-31ยฃ10.53 B54.45%
2012-12-31ยฃ6.82 B59.42%
2011-12-31ยฃ4.27 B78.95%
2010-12-31ยฃ2.39 B886.4%
2009-12-31ยฃ0.24 B457.76%
2008-12-31ยฃ43.46 M
2006-12-31ยฃ0.20 B-17.27%
2005-12-31ยฃ0.25 B1.55%
2004-12-31ยฃ0.24 B-45.08%
2003-12-31ยฃ0.45 B-2.55%
2002-12-31ยฃ0.46 B1364.01%
2001-12-31ยฃ31.83 M-93.57%
2000-12-31ยฃ0.49 B481.63%
1999-12-31ยฃ85.09 M11.51%
1998-12-31ยฃ76.31 M2458.49%
1997-12-31ยฃ2.98 M-27.03%
1996-12-31ยฃ4.08 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.40 B-97.62%๐Ÿ‡บ๐Ÿ‡ธ USA